BLT benitec biopharma limited

strategy, page-6

  1. 2,327 Posts.
    lightbulb Created with Sketch. 12
    Whilst preserving the chance at such a HBV Chinese
    tender benitec would still do well to look at getting much more leverage out of its tt-033 HCV stake than it's present ~ 5%. Chinese gov getting hold of Asian rights to tt-033 would be enough of a catalyst to fire other shRNA proof of concepts into life.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.